Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-09-25 | Mrs. Alltoft was appointed as a director on March 4, 2019. She serves on the Nominating and Governance Committee. Compensation paid to Jennifer S. Alltoft was $54,245 during the year ended March 31, 2019. |
| 2020-07-17 | Jennifer Alltoft was appointed as a director on March 4, 2019. ... The members of the Nominating and Governance Committee during the year ended March 31, 2020 were Mr. Schmieder (Chairperson), Ms. Alltoft, and Mr. Dwyer. |
| 2021-07-16 | Jennifer Alltoft was appointed as a director on March 4, 2019. Ms. Alltoft had a 32-year career at Pfizer, Inc., where she held multiple positions in Research and Development, Sales and Marketing, and General Management including Global Leadership of Pfizer’s Biosimilar Division. ... The members of the Audit Committee are Messrs. Guillemin (Chairperson) and Schmieder and Ms. Alltoft. ... The members of the Nominating and Governance Committee during fiscal year 2021 were Mr. Schmieder (Chairperson), Ms. Alltoft, and Ms. Hall. ... As of May 2021, Shannon M. Hall was appointed as a member of the Compensation Committee. ... The compensation paid to each non-employee director who served during fiscal year 2021 is set forth below. ... Jennifer S. Alltoft Fees Earned or Paid in Cash ($): - Stock Awards ($): 136,502 All Other Compensation ($): - Total ($): 136,502. |
| 2022-07-14 | Jennifer Alltoft was appointed as a director on March 4, 2019. ... The members of the Audit Committee are Messrs. Guillemin (Chairperson) and Schmieder and Ms. Alltoft. ... The Nominating and Governance Committee met two times during fiscal year 2022. The members of the Nominating and Governance Committee during fiscal year 2022 were Mr. Schmieder (Chairperson), Ms. Alltoft, and Ms. Hall. ... The compensation paid to each non-employee director who served during fiscal year 2022 is set forth below. Jennifer S. Alltoft: $165,116. |
| 2023-07-14 | Jennifer S. Alltoft SVP - Business Development and Commercialization, Sumitovant Biopharma, Ltd. Age 55 Director since 2019 X ✔ Chair ... The compensation paid to each non-employee director who served during fiscal year 2023 is set forth below. Jennifer S. Alltoft Fees Earned or Paid in Cash ($) 60,000 Stock Awards ($) 150,099 Total ($) 210,099 |
| 2024-07-19 | Jennifer S. Alltoft SVP - Business Development and Commercialization, Sumitovant Biopharma, Ltd. |
Data sourced from SEC filings. Last updated: 2025-08-30